Please assess the completion status of the following clinical trial:

Trial Title: Stanford Accelerated Recovery Trial (START)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
INCLUSION CRITERIA~* Age 18 to 75~* Undergoing a scheduled surgery~* English speaking~* Ability and willingness to complete questionnaires or use Palm Pilot~EXCLUSION CRITERIA~* Known kidney disease~* Currently receiving gabapentin or (pregabalin) lyrica already~* Cognitive impairment~* Previous history of excessive sedation or adverse reaction to gabapentin (not it was tried but ineffective for nerve pain)~* Coexisting chronic pain \> 4/10 disorder in area other than surgical target~* Plan to move out of state~* Condition that would in judgment of team member make patient likely to be lost to follow-up~* Elevated suicidality~* Known pregnancy~* Current symptoms of ataxia, dizziness, or sedation~* Narrow angle glaucoma~* Severe respiratory insufficiency (ie, severe emphysema or chronic obstructive pulmonary disease)~* History of gastric bypass surgery and obstructive sleep apnea requiring continuous positive airway pressure (CPAP)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Control (Type: PLACEBO_COMPARATOR): Active placebo given pre-operatively, followed by inactive placebo for 10 doses post-operatively
- Gabapentin (Type: EXPERIMENTAL): 1200 mg Gabapentin preoperative dose, 300 mg of Gabapentin 3-times a day postoperative doses for 72-hour post-surgical period.

Based on this trial design, predict the completion outcome and termination type (if applicable).